News

Khona Scientific to Focus Frontier Bio-Manufacturing Technology on Production of Small-Molecule KSMs and APIs

Next-generation BiDS™ synthetic biology platform to power on-demand, sovereign production of essential medicines and their precursors. BOULDER, CO, UNITED STATES, July 10, 2026 /EINPresswire.com/ -- Khona Scientific, a pioneer of advanced biomanufacturing solutions for complex...

Read More

Khona Scientific Appoints Michael A. Gonzalez, PhD, to Board of Directors

Dr. Gonzalez will bring valuable manufacturing and regulatory expertise to Khona Scientific as it expands production of pharmaceutical key starting materials. BOULDER, CO, UNITED STATES, May 5, 2026 /EINPresswire.com/ -- Khona Scientific Inc., a synthetic...

Read More

Khona Scientific Inc. Accepted Into the BioMaP Consortium

BOULDER, CO, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- Khona Scientific Inc. is pleased to announce that it has been accepted into the Biopharmaceutical Manufacturing Preparedness (BioMaP) Consortium, a BARDA-supported public-private partnership focused on strengthening...

Read More

Khona Scientific & Benuvia Operations Sign LOI to Advance Biosynthetic Development of Controlled-Substance APIs

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical manufacturing. LONE TREE, CO, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Benuvia Operations, LLC (“Benuvia”), a U.S.-based pharmaceutical...

Read More

Khona Scientific Inc. Expands Operations with New Cutting Edge Lab Space in Boulder, CO

LONE TREE, CO, UNITED STATES, November 14, 2024 /EINPresswire.com/ -- Khona Scientific Inc., a synthetic biotechnology company and leader in the biosynthetic production of complex compounds, is excited to announce the acquisition of new and...

Read More